VEGFR-3 fusion proteins

Research output: Patent

Abstract

The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
Original languageEnglish
Publication Year9 Sep 2008
Publication statusPublished - 9 Sep 2008
MoE publication typeH1 Granted patent

Cite this

Alitalo, K. K., & Jeltsch, M. M. (2008). VEGFR-3 fusion proteins. (Patent No. US 7,422,741 B2). US Patent and Trademark Office.